TY - JOUR
T1 - Disseminated Enteroviral Infection Associated with Obinutuzumab
AU - Dendle, Claire
AU - Gilbertson, Michael
AU - Korman, Tony
AU - Golder, Vera
AU - Morand, Eric Francis
AU - Opat, Stephen
PY - 2015
Y1 - 2015
N2 - Two cases of disseminated enteroviral infection occurred in patients who received the CD20 monoclonal antibody obinutuzumab. Clinical features included hepatitis, edema, and a dermatomyositis-like syndrome. These manifestations may be unfamiliar to clinicians and are possibly responsive to intravenous immunoglobulin. Clinicians should remain vigilant for enteroviral infections in patients receiving obinutuzumab.
AB - Two cases of disseminated enteroviral infection occurred in patients who received the CD20 monoclonal antibody obinutuzumab. Clinical features included hepatitis, edema, and a dermatomyositis-like syndrome. These manifestations may be unfamiliar to clinicians and are possibly responsive to intravenous immunoglobulin. Clinicians should remain vigilant for enteroviral infections in patients receiving obinutuzumab.
UR - http://www.ncbi.nlm.nih.gov/pubmed/26291712
UR - https://www.scopus.com/pages/publications/84939529420
U2 - 10.3201/eid2109.150104
DO - 10.3201/eid2109.150104
M3 - Article
SN - 1080-6040
VL - 21
SP - 1661
EP - 1663
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 9
ER -
